121 related articles for article (PubMed ID: 20596715)
1. Metformin 2,500 mg/day in the treatment of obese women with polycystic ovary syndrome and its effect on weight, hormones, and lipid profile.
Aghahosseini M; Aleyaseen A; Safdarian L; Moddaress-Hashemi S; Mofid B; Kashani L
Arch Gynecol Obstet; 2010 Dec; 282(6):691-4. PubMed ID: 20596715
[TBL] [Abstract][Full Text] [Related]
2. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
3. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
Ibáñez L; De Zegher F
Hum Reprod; 2004 Aug; 19(8):1725-7. PubMed ID: 15229206
[TBL] [Abstract][Full Text] [Related]
4. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
5. The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome.
Oppelt PG; Mueller A; Jentsch K; Kronawitter D; Reissmann C; Dittrich R; Beckmann MW; Cupisti S
Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):633-7. PubMed ID: 19998243
[TBL] [Abstract][Full Text] [Related]
6. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
[TBL] [Abstract][Full Text] [Related]
7. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
[TBL] [Abstract][Full Text] [Related]
8. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
[TBL] [Abstract][Full Text] [Related]
9. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
Maciel GA; Soares Júnior JM; Alves da Motta EL; Abi Haidar M; de Lima GR; Baracat EC
Fertil Steril; 2004 Feb; 81(2):355-60. PubMed ID: 14967373
[TBL] [Abstract][Full Text] [Related]
10. Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.
Harborne LR; Sattar N; Norman JE; Fleming R
J Clin Endocrinol Metab; 2005 Aug; 90(8):4593-8. PubMed ID: 15886247
[TBL] [Abstract][Full Text] [Related]
11. Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome.
Nawaz FH; Rizvi J
Gynecol Obstet Invest; 2010; 69(3):184-9. PubMed ID: 20029224
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S
Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
[TBL] [Abstract][Full Text] [Related]
14. [Lipid profile in obese and non-obese women with polycystic ovary syndrome treated with metformin].
Quintero-Castillo D; Luz-Araujo H; Guerra-Velázquez M; Reyna-Villasmil E; Santos Bolívar J; Torres-Cepeda D; Mejia-Montilla J; Reyna-Villasmil N
Endocrinol Nutr; 2010; 57(6):262-7. PubMed ID: 20547115
[TBL] [Abstract][Full Text] [Related]
15. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
Khorram O; Helliwell JP; Katz S; Bonpane CM; Jaramillo L
Fertil Steril; 2006 May; 85(5):1448-51. PubMed ID: 16579997
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two doses of metformin (2.5 and 1.5 g/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference.
Bruno RV; de Avila MA; Neves FB; Nardi AE; Crespo CM; Sobrinho AT
Fertil Steril; 2007 Aug; 88(2):510-2. PubMed ID: 17433315
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A
J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799
[TBL] [Abstract][Full Text] [Related]
18. Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
Rautio K; Tapanainen JS; Ruokonen A; Morin-Papunen LC
Eur J Endocrinol; 2005 Feb; 152(2):269-75. PubMed ID: 15745936
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study.
Kazerooni T; Shojaei-Baghini A; Dehbashi S; Asadi N; Ghaffarpasand F; Kazerooni Y
Fertil Steril; 2010 Nov; 94(6):2208-13. PubMed ID: 20079899
[TBL] [Abstract][Full Text] [Related]
20. Metformin in the treatment of clomiphene citrate-resistant women with high BMI and primary infertility: clinical results and reproductive outcome.
Qublan HS; Malkawi HY
J Obstet Gynaecol; 2005 Jan; 25(1):55-9. PubMed ID: 16147697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
